APG-115 in Salivary Gland Cancer Trial

NCT03781986 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Malignant Salivary Gland Cancer
Salivary Gland Cancer

Interventions

DRUG: APG-115
DRUG: Carboplatin

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]